Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

glioma resection using Myriad NOVUS
January 7, 2020/Cancer

First U.S. Clinical Use of Next-Generation Device Brings New Light to Brain Resections

Cleveland Clinic surgeons remove first brain tumor with Myriad NOVUS tool

Prostate SAbR 650×450
December 27, 2019/Cancer/Radiation Oncology

Testing the Ability to Preserve Erectile Function While Using Stereotactic Ablative Body Radiotherapy for Localized Prostate Cancer

Clinical trial investigates nerve-sparing approach

cancer-care_650x450
December 26, 2019/Cancer/News & Insight

Shortening the Wait for Cancer Treatment

Sustained success requires a cultural shift

650×450-Cancer
December 20, 2019/Cancer/News & Insight

Moments in Time

For a cancer doctor, patients’ photographs are small windows into their condition

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-invasive-lobular-breast-cancer
December 12, 2019/Cancer/Research

No Survival Advantage from Chemo-endocrine Therapy over Endocrine Therapy in Invasive Lobular Carcinoma

Study suggests limited role for CET in this cancer type

giant platelets
December 11, 2019/Cancer

An Improbable Aortic Surgery in the Setting of Giant Platelet Disorder

Multidisciplinary collaboration enables first such operation in a patient with MYH9 mutation

Seth Rotz, MD
December 10, 2019/Cancer

Higher Risk of Low Bone Mineral Density and Fractures in Survivors of Childhood Hematologic Cancers

Study affirms the need for prevention and monitoring

QD-Follicular-Lymphoma-WINTER
December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

T-cells_650x450
December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

QD-Myelofibrosis-GERDS
December 9, 2019/Cancer/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

BackPage 59 of 112Next

Advertisement

Ad